Clinical trialObservationalCompleted
Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment
Continuous Glucose Monitoring For Prediction and Treatment of Steroid-Induced Hyperglycemia
- Outcome
- Finished, no results posted
- Phase
- Observational
- Status
- Completed
- Study type
- Observational
- Start
- 20 December 2019
- Ended
- 31 October 2023
- Enrollment
- 3 participants
- Sites
- 1
- Primary outcomes
- severe hyperglycemia
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 1 November 2023
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this study is to see if continuous glucose monitoring can identify how often people who have pre-diabetes or medical obesity or well-controlled diabetes experience very high glucose values while receiving chemotherapy for breast cancer or pancreatic.